919 related articles for article (PubMed ID: 30429347)
1. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
2. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
3. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
4. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
Glennon NB; Jabado O; Lo MK; Shaw ML
J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
[TBL] [Abstract][Full Text] [Related]
6. Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.
Nehls J; Businger R; Hoffmann M; Brinkmann C; Fehrenbacher B; Schaller M; Maurer B; Schönfeld C; Kramer D; Hailfinger S; Pöhlmann S; Schindler M
Cell Rep; 2019 Feb; 26(7):1841-1853.e6. PubMed ID: 30759394
[TBL] [Abstract][Full Text] [Related]
7. Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein.
Paparisto E; Hunt NR; Labach DS; Coleman MD; Di Gravio EJ; Dodge MJ; Friesen NJ; Côté M; Müller A; Hoenen T; Barr SD
Cells; 2021 Sep; 10(9):. PubMed ID: 34572049
[TBL] [Abstract][Full Text] [Related]
8. Unique Evolution of Antiviral Tetherin in Bats.
Hayward JA; Tachedjian M; Johnson A; Irving AT; Gordon TB; Cui J; Nicolas A; Smith I; Boyd V; Marsh GA; Baker ML; Wang LF; Tachedjian G
J Virol; 2022 Oct; 96(20):e0115222. PubMed ID: 36173189
[TBL] [Abstract][Full Text] [Related]
9. Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication.
Seifert SN; Letko MC; Bushmaker T; Laing ED; Saturday G; Meade-White K; van Doremalen N; Broder CC; Munster VJ
J Infect Dis; 2020 May; 221(Suppl 4):S407-S413. PubMed ID: 31682727
[TBL] [Abstract][Full Text] [Related]
10. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.
Kong WS; Irie T; Yoshida A; Kawabata R; Kadoi T; Sakaguchi T
Hiroshima J Med Sci; 2012 Sep; 61(3):59-67. PubMed ID: 23077864
[TBL] [Abstract][Full Text] [Related]
12. Ebolavirus Replication and Tetherin/BST-2.
Yasuda J
Front Microbiol; 2012; 3():111. PubMed ID: 22485110
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells.
Kühl A; Hoffmann M; Müller MA; Munster VJ; Gnirss K; Kiene M; Tsegaye TS; Behrens G; Herrler G; Feldmann H; Drosten C; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S840-9. PubMed ID: 21987760
[TBL] [Abstract][Full Text] [Related]
14. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
15. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cells Generated From
Edenborough KM; Bokelmann M; Lander A; Couacy-Hymann E; Lechner J; Drechsel O; Renard BY; Radonić A; Feldmann H; Kurth A; Prescott J
Front Immunol; 2019; 10():2414. PubMed ID: 31681302
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Genomic Characterization of a Novel Henipavirus, Angavokely Virus, from Fruit Bats in Madagascar.
Madera S; Kistler A; Ranaivoson HC; Ahyong V; Andrianiaina A; Andry S; Raharinosy V; Randriambolamanantsoa TH; Ravelomanantsoa NAF; Tato CM; DeRisi JL; Aguilar HC; Lacoste V; Dussart P; Heraud JM; Brook CE
J Virol; 2022 Sep; 96(18):e0092122. PubMed ID: 36040175
[TBL] [Abstract][Full Text] [Related]
18. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
Zumbrun EE
Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
[TBL] [Abstract][Full Text] [Related]
19. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
Monath TP; Nichols R; Tussey L; Scappaticci K; Pullano TG; Whiteman MD; Vasilakis N; Rossi SL; Campos RK; Azar SR; Spratt HM; Seaton BL; Archambault WT; Costecalde YV; Moore EH; Hawks RJ; Fusco J
PLoS Pathog; 2022 Jun; 18(6):e1010658. PubMed ID: 35759511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]